Peter Lane

Prof

Accepting PhD Students

PhD projects

Professor Lane and his group are currently focused on understanding:

The regulation of OX40-ligand on LTi, as switching off expression (as in the embryo) would be a very effective way to suppress CD4-mediated diseases
How human LTi might be modified in disease to cause secondary CD4 immunodeficiency.

19972022

Research activity per year

Network

Graham Anderson

Person: Academic

David Withers

Person: Academic

Jorge Caamano

Person: Honorary

Adam Cunningham

Person: Academic

Lavanya Diwakar

Person: Honorary

Andrew Gennery

  • Newcastle University

External person

M. Kim

  • Gangneung-Wonju National University
  • Yonsei University

External person

Hideo Yagita

  • Department of Immunology; Juntendo University School of Medicine; Tokyo Japan

External person

William Bermingham

  • Heartlands Hospital

External person

Stephen Jolles

  • University Hospital of Wales

External person

Josef M Penninger

  • Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)
  • University of British Columbia

External person

Siraj A Misbah

  • Oxford University Hospitals NHS Foundation Trust

External person

Andrew S. Austin

  • Royal Derby Hospital

External person

S. Kim

  • Sejong University

External person

Philip Bright

  • European School of Osteopathy

External person

Sarah Goddard

  • University Hospitals of North Midlands NHS Trust

External person

Fatima Dhalla

  • University of Oxford

External person

David M. Lowe

  • University College London

External person

Arnauld Serge

  • Aix Marseille University

External person